title: The type I serine/threonine kinase receptor Alk8/Lost-a-fin is required for Bmp2b/7 signal transduction during dorsoventral patterning of the zebrafish embryo.
abstract: Ventral specification of mesoderm and ectoderm depends on signaling by members of the bone morphogenetic protein (Bmp) family. Bmp signals are transmitted by a complex of type I and type II serine/threonine kinase transmembrane receptors. Here, we show that Alk8, a novel member of the Alk1 subgroup of type I receptors, is disrupted in zebrafish lost-a-fin (laf) mutants. Two alk8/laf null alleles are described. In laf(tm110), a conserved extracellular cysteine residue is replaced by an arginine, while in laf(m100), Alk8 is prematurely terminated directly after the transmembrane domain. The zygotic effect of both mutations leads to dorsalization of intermediate strength. A much stronger dorsalization, similar to that of bmp2b/swirl and bmp7/snailhouse mutants, however, is obtained by inhibiting both maternally and zygotically supplied alk8 gene products with morpholino antisense oligonucleotides. The phenotype of laf mutants and alk8 morphants can be rescued by injected mRNA encoding Alk8 or the Bmp-regulated transcription factor Smad5, but not by mRNA encoding Bmp2b or Bmp7. Conversely, injected mRNA encoding a constitutively active version of Alk8 can rescue the strong dorsalization of bmp2b/swirl and bmp7/snailhouse mutants, whereas smad5/somitabun mutant embryos do not respond. Altogether, the data suggest that Alk8 acts as a Bmp2b/7 receptor upstream of Smad5.
authors.affiliation: Hans-Spemann Laboratory, Max-Planck Institut für Immunbiologie, Stuebeweg 51, D-79108 Freiburg, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Bauer
authors.forename: Z
authors.initials: Z
authors.lastname: Lele
authors.forename: G J
authors.initials: GJ
authors.lastname: Rauch
authors.forename: R
authors.initials: R
authors.lastname: Geisler
authors.forename: M
authors.initials: M
authors.lastname: Hammerschmidt
mesh_terms: D029404:Activin Receptors; D000818:Animals; D019521:Body Patterning / Q000502:physiology*; D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000502:physiology*; D003001:Cloning, Molecular; D003433:Crosses, Genetic; D004625:Embryo, Nonmammalian / Q000502:physiology*; D008040:Genetic Linkage; D005838:Genotype; D016296:Mutagenesis; D010641:Phenotype; D010802:Phylogeny; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000502:physiology*; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta; D015027:Zebrafish / Q000196:embryology* / Q000235:genetics; D029961:Zebrafish Proteins
chemical_list: D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta; D029961:Zebrafish Proteins; C405936:bmp2b protein, zebrafish; C525826:bmp7a protein, zebrafish; D017346:Protein Serine-Threonine Kinases; D029404:Activin Receptors